NCT07028853 · Interventional trial
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Overall registry status Recruiting
Phase 3
Conditions Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Prostate Cancer
Delaware Valley sites
- MidLantic urology · Bala-Cynwyd, PA · Montgomery County · Recruiting
First posted
Registry updated
Added to the directory